Research memoBaxter International Inc. (BAX) · NYSEMemo of October 31, 2026By Olivier Lachance

Baxter International dividend

MyStockButler's October 2026 analysis: Baxter International currently pays $0.01 per share quarterly, while its forecast base case keeps the dividend at $0.04 per share in each twelve-month window. Baxter International generated $438 million of free cash flow in 2025, so the present payout is small relative to that cash, though debt reduction and investment still compete for it.

0.68
Dividend paid per share, 2025
0.2%
Dividend yield
2.7%
Real free cash flow yield
3.7%
Free cash flow yield
Read the full Baxter International memoYour first S&P 500 report is free · no card
Every number traced to Baxter International's filings8 chapters · 21,232 words180 sources cited

How much does Baxter International pay in dividends?

Baxter International (BAX) dividend per share: $1.04 paid in 2021, $0.68 in 2025; our forecast: $0.04 in Oct 2029; dividend yield 0.2 %

Shareholders received more cash during the earlier, more pressured years. Baxter paid $1.130 billion in dividends and buybacks in 2021, including $600 million of buybacks. In 2022, shareholder payments of $605 million exceeded free cash flow of $151 million. By 2024, dividends alone were $590 million against $373 million of free cash flow. Those distributions competed with factories, quality work and debt repayment.

The board cut the quarterly dividend from $0.17 to $0.01 beginning with the January 2026 payment. Baxter made no share repurchases in 2023–2025 or in the first nine months of 2026. That preserved cash for the balance sheet.

ResultsUS$ millions; per share in US$
20252024202320222021
Revenue11,24410,63610,36010,057
EPS, diluted-1.75-0.640.36-6.18
Dividend per share0.521.041.161.151.09

Is Baxter International's dividend covered by its cash?

After Hillrom, Baxter increasingly directed cash toward keeping the business running and reducing debt. Free cash flow means operating cash left after spending on property and equipment. In 2025, Baxter spent $513 million on capital equipment and produced $438 million of free cash flow. The household analogy is useful: operating cash is income after ordinary bills, while capital spending buys or replaces the furnace and delivery van needed to keep going.

Follow the money: where the free cash flow wentUS$ millions
20252024202320222021
Free cash flow438373775151
− Dividends paid348590586573530
− Share buybacks00032600
Paid to shareholders3485905866051,130
Paid out, % of free cash flow79.5%158.2%75.6%400.7%

What this means. The payout can exceed one hundred percent because it compares money paid to shareholders with free cash flow after subtracting stock-based pay, which leaves a smaller amount.

Dividend per share against free cash flow per share (US$ per share)1.0420211.140.0220221.151.3020231.160.5120240.680.632025Dividends paid, per shareReal free cash flow per share

What could change Baxter International's dividend?

The base dividend stays at $0.04 per share in each twelve-month window. That matches the current $0.01 quarterly rate. The bear pays $0.04 in the first window, then suspends the dividend as cash priorities intensify. The bull rises to $0.08 and then $0.12 as execution improves. The sharp reduction from earlier payouts and Baxter’s investment needs make the flat base path most credible.

The base case would strengthen if Baxter delivered its 3%–4% organic sales outlook, generated repeatable cash and reduced debt while continuing factory and quality investment. The multiple would remain restrained if Vantive costs outlast its service payments.

The forecast's tablebase case, then bear / bull in brackets; USD millions, per share in USD, unless shown
October 2027October 2028October 2029
Earnings1,109 (853 / 1,196)1,170 (819 / 1,293)1,221 (796 / 1,380)
Dividends per share0.04 (0.04 / 0.04)0.04 (0.00 / 0.08)0.04 (0.00 / 0.12)
Price to earnings11.00 (8.00 / 14.00)11.00 (7.00 / 15.00)10.50 (6.50 / 16.00)
From the full memo · 1. The business

Baxter International sells the fluids, medicines, devices and surgical products that hospitals use to care for patients. Its business is easiest to understand as a chain: hospitals and their buying partners pay for treatment supplies and equipment, while Baxter spends to make, deliver and support them.

Continue reading, free
Your first S&P 500 report is free · no card

Where these numbers come from

More on Baxter International

Baxter International stock forecastBaxter International earningsAuf Deutsch

Its rivals

BD (BDX)GE HealthCare (GEHC)Pfizer (PFE)

Browse

All stocksS&P 500 companiesCompanies B
The full Baxter International memoYour first S&P 500 report is free
Read it